Autologous Umbilical Cord Blood
Sponsors
Michael Cotten, Duke University, The University of Texas Health Science Center, Houston, Guangdong Women and Children Hospital, Fundatia Bio-Forum
Conditions
Autism Spectrum DisorderAutistic Spectrum DisorderCongenital Diaphragmatic HerniaEffect of DrugsHypoplastic Left Heart SyndromeSafety IssuesSafety Issues;Effect of Drugs
Phase 1
Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome
TerminatedNCT01445041
Start: 2011-09-01End: 2016-04-15Updated: 2024-05-16
Autologous Umbilical Cord Blood Infusion for Children With Autism Spectrum Disorder (ASD)
CompletedNCT02176317
Start: 2014-06-30End: 2015-12-31Updated: 2019-12-03
Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH)
TerminatedNCT03526588
Start: 2018-08-01End: 2024-07-01Updated: 2024-07-11
Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy
NCT03791372
Start: 2017-10-10End: 2021-04-10Target: 25Updated: 2019-01-04
Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder
CompletedNCT04007224
Start: 2019-01-17End: 2023-07-10Updated: 2023-08-23
Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Autism Spectrum Disorder
NCT04768816
Start: 2019-07-01End: 2024-12-31Target: 25Updated: 2021-02-24